Cabbacis receives Canadian patent for low-nicotine tobacco and cannabis pod

Cabbacis, a US federal licensed tobacco product manufacturer that focuses on reducing the harmful effects of its products, has announced that Canada's Intellectual Property Office (CIPO) has granted a patent for its pod. The pod contains a mixture of very low nicotine tobacco and cannabis for use in electronic cigarettes.

The Canadian Patent number 3,151,047 has been granted to Cabbacis, which includes 27 claims and will expire on September 10, 2040. In early 2022, the Canadian Intellectual Property Office (CIPO) also granted Patent number 3,107,796 to Cabbacis for cigarettes containing a mixture of extremely low nicotine tobacco and cannabis.

We are thrilled that both of our products have now received patents in Canada, which was one of our early target countries for commercialization," said Joseph Pandolfino, founder and CEO of Cabbacis.

The company's ultra-low nicotine cigarettes and soon-to-be-released electronic pods containing a mix of ultra-low nicotine tobacco and cannabis are primarily aimed at helping traditional cigarette smokers reduce their smoking habit and transition to less harmful tobacco nicotine products or quit nicotine altogether.

Cabbacis has a portfolio of patents that includes 25 authorized patents and various pending patent applications in the United States, Europe, China, Japan, South Korea, Canada, Australia, New Zealand, Mexico, Brazil, and other countries and regions. The company already owns six patents in the United States.